When I visited Kirit Nursing Home for an in-depth medical interview, I aimed to understand how modern gynecologic oncology is transforming women’s health in India. My discussion with Dr. Maitreyee Parulekar—one of the specialists known for Cervical precancer treatment in Mumbai—revealed a compelling shift in how early lesions, dysplasia, and pre-malignant cervical conditions are being managed today. As a medical journalist, witnessing her clinical approach first-hand helped me appreciate the precision and caution involved in preventing cervical cancer progression. During our conversation, she emphasized the importance of early screening and minimally invasive approaches, highlighting why many consider her insights crucial for women seeking reliable care for Cervical precancer treatment in Mumbai.
According to information available on her official medical profile, Dr. Maitreyee Parulekar has undergone extensive training in gynecology, gynecologic oncology, and advanced cancer care. Her educational background includes medical graduation and specialized surgical training, positioning her among the Top Gynae Oncologist in Mumbai. With years of clinical expertise, she has managed a broad spectrum of gynecologic cancers and precancerous conditions, blending diagnostic accuracy with experience-driven surgical judgment.
Kirit Nursing Home reflects a systematic, patient-centered environment. The facility maintains a well-equipped setup suited for screening, diagnosis, and treatment of cervical precancerous changes. Consultation rooms are designed for cervical assessments, including colposcopy, cytology review, imaging interpretation, and pre-surgical planning. The staff maintains a calm, coordinated workflow that patients find reassuring—an essential quality for those seeking a dependable Gynecologist in Vile Parle, Mumbai.
When discussing cervical precancer, Dr. Maitreyee Parulekar explained that it is not cancer but a condition where abnormal cells begin to appear on the cervix. She emphasized the importance of early detection through Pap smears, HPV testing, and colposcopic examination. Most precancerous lesions result from persistent high-risk HPV infections and can be treated effectively before they progress into cervical cancer.
She clarified that cervical intraepithelial neoplasia (CIN) is categorized into different grades:
According to her, treating precancerous lesions early can prevent up to 90% of cervical cancer cases—a statistic that underscores why awareness, screening, and timely treatment are essential.
Dr. Maitreyee Parulekar described multiple treatments used based on lesion severity and patient-specific factors: